neuropilin-1 receptor antagonists (Eyecopharm)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameneuropilin-1 receptor antagonists (Eyecopharm)
Drug Alias NameNRP-1 antagonist (Ark Therapeutics)NP-1 antagonist (Ark Therapeutics)EG-00229EG-3287EG-01257 +[7] 
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionNeuropilin-1 inhibitorsAngiogenesis inhibitorsVascular endothelial growth factor receptor antagonists +[4] 
TargetsNeuropilin-1Vascular endothelial growth factor receptor
Therapy Area/IndicationsMacular DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPremier Veterinary Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEyecopharm AGPremier Veterinary Group Plc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A